Sequenom Announces New Positive Data on Down Syndrome Detection and – PR Inside
Sequenom, Inc. (NASDAQ:SQNM) today announced new positive data from the prospective clinical studies using the Company’s noninvasive SEQureDx” technology, enabling the detection of fetal aneuploidy from maternal blood. The data presented today
Sequenom Announces New Positive Data on Down Syndrome Detection and – PR Inside
February 3, 2009 By Leave a Comment
Speak Your Mind
You must be logged in to post a comment.

